Related references
Note: Only part of the references are listed.Prime-boost vectored malaria vaccines Progress and prospects
Adrian V. S. Hill et al.
HUMAN VACCINES (2010)
Cross-Talk between T Cells and NK Cells Generates Rapid Effector Responses to Plasmodium falciparum-Infected Erythrocytes
Amir Horowitz et al.
JOURNAL OF IMMUNOLOGY (2010)
Evaluation of the Safety and Immunogenicity of the RTS,S/AS01E Malaria Candidate Vaccine When Integrated in the Expanded Program of Immunization
Selidji T. Agnandji et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Follicular helper T cells as cognate regulators of B cell immunity
Louise J. McHeyzer-Williams et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia
Kalifa Bojang et al.
HUMAN VACCINES (2009)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
Mark E. Polhemus et al.
PLOS ONE (2009)
A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon
Bertrand Lell et al.
PLOS ONE (2009)
Randomized Controlled Trial of RTS,S/AS02D and RTS,S/AS01E Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children
Seth Owusu-Agyei et al.
PLOS ONE (2009)
B-cell responses to vaccination at the extremes of age
Claire-Anne Siegrist et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Cellular effector mechanisms against Plasmodium liver stages
Ute Frevert et al.
CELLULAR MICROBIOLOGY (2008)
IL-2 producing memory CD4+ T lymphocytes are closely associated with the generation of IgG-secreting plasma cells
Nicolle H. R. Litjens et al.
JOURNAL OF IMMUNOLOGY (2008)
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Philip Bejon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
Salim Abdulla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen
Pascal Mettens et al.
VACCINE (2008)
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique:: a double blind randomised controlled phase I/IIb trial
John J. Aponte et al.
LANCET (2007)
Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A
V. Ann Stewart et al.
VACCINE (2006)
Differentiation of memory B and T cells
Vandana Kalia et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children:: single-blind extended follow-up of a randomised controlled trial
PL Alonso et al.
LANCET (2005)
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
PL Alonso et al.
LANCET (2004)
Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-γ
PF Sun et al.
JOURNAL OF IMMUNOLOGY (2003)
Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia:: a randomised trial
KA Bojang et al.
LANCET (2001)
Immunofluorescence analysis of T-cell responses in health and disease
HT Maecker et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2000)